GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are helping millions of people lose significant weight. The results on the scale are real. But there is a problem most people do not discover until it is too late.
Some of that weight you are losing is muscle.
Not all of it. Not even most of it. But enough to matter. Clinical research shows that a meaningful percentage of the total weight lost on GLP-1 medications comes from lean body mass, not just fat. And unlike fat, muscle does not come back easily. Losing it quietly while celebrating the number on the scale is one of the most overlooked risks of rapid weight loss in 2026.
This guide covers why it happens, why it matters, and the five evidence-based strategies that can help you preserve your lean muscle while still getting every benefit from your GLP-1 medication.
Why GLP-1 Medications Cause Muscle Loss
GLP-1 receptor agonists (like semaglutide and tirzepatide) work by mimicking a natural hormone called glucagon-like peptide-1. This hormone reduces appetite, slows stomach emptying, and helps regulate blood sugar. The result is a significant reduction in calorie intake, which drives weight loss.
Here is the biological reality: when you eat substantially fewer calories than your body needs, your body does not just burn fat. It also breaks down some muscle tissue for energy. This happens with any form of weight loss, not just GLP-1 medications. But GLP-1s can accelerate the process because the appetite suppression is so effective that many users eat far less protein than their muscles need to maintain themselves.
The research confirms this. Studies on semaglutide have shown that lean body mass can account for a meaningful portion of total weight lost. Some analyses put this figure between 25% and 40% of total weight reduction, depending on the individual, dosage, diet, and activity level.
Why Losing Muscle Is a Bigger Problem Than Most People Realize
Muscle is not just about aesthetics. It is metabolically active tissue that affects almost every aspect of your health:
- Metabolism: Muscle burns more calories at rest than fat. Losing muscle slows your resting metabolic rate, making it harder to keep weight off long term and increasing the likelihood of regaining fat after stopping medication.
- Strength and function: Less muscle means less strength. Daily activities become harder. Injury risk increases. For people over 40, this accelerates the natural age-related decline in physical function.
- Blood sugar regulation: Muscle tissue is a major site for glucose disposal. Losing muscle can actually undermine one of the primary goals of GLP-1 therapy, which is blood sugar management.
- Bone health: Muscle and bone health are closely connected. Significant muscle loss can contribute to reduced bone density over time.
- Rebound risk: People who lose muscle during weight loss are more likely to regain weight as fat. The result is a worse body composition than before they started, even at the same scale weight.
The core problem: The scale says you are winning. But if a significant portion of that weight loss is muscle, you may be setting yourself up for metabolic slowdown, strength loss, and weight regain. The goal should never be "lose weight." The goal should be "lose fat, keep muscle."
Protect Your Muscle While You Lose Fat
SURGE 185 delivers 2,400mg of PeptiStrong, clinically shown to support muscle protein synthesis and accelerate recovery. Non-hormonal. Stimulant-free.
5 Evidence-Based Strategies to Preserve Muscle on GLP-1s
The good news: muscle loss on GLP-1 medications is not inevitable. With the right approach, you can preserve the vast majority of your lean mass while still losing fat. Here are the five strategies with the strongest evidence behind them.
This is the single most effective strategy for preserving muscle during weight loss, with or without GLP-1 medication. Resistance training sends a direct signal to your body that your muscles are needed and should not be broken down for energy.
What the evidence says: Multiple studies have demonstrated that combining resistance exercise with caloric restriction significantly reduces the proportion of lean mass lost compared to caloric restriction alone. This applies to GLP-1 users just as much as anyone else on a caloric deficit.
Minimum effective protocol:
- 2 to 3 sessions per week of resistance training (weights, machines, or bodyweight)
- Focus on compound movements: squats, deadlifts, presses, rows, lunges
- Progressive overload: gradually increase weight or reps over time
- Each session does not need to be long. 30 to 45 minutes of focused work is sufficient
If you are not currently resistance training and you are on a GLP-1 medication, starting a basic program is the single highest-impact change you can make to protect your muscle.
GLP-1 medications suppress appetite aggressively. Many users eat significantly less food overall, which often means significantly less protein. This creates a double problem: your body is in a caloric deficit (which promotes muscle breakdown) and it does not have enough amino acids to repair and maintain existing muscle tissue.
Target intake: Aim for 1.2 to 1.6 grams of protein per kilogram of body weight per day. For a 180-pound (82kg) person, that means 98 to 131 grams of protein daily. This is higher than the general population recommendation, but research supports elevated protein intake during weight loss to preserve lean mass.
Practical tips when appetite is low:
- Prioritize protein at every meal (eat the protein portion first)
- Use liquid protein sources (shakes, smoothies) when solid food feels unappealing
- Choose protein-dense foods: Greek yogurt, eggs, chicken breast, fish, cottage cheese
- Consider a whey or plant protein supplement to hit your daily target
Here is the gap that most GLP-1 muscle preservation advice misses. Eating enough protein gives your body the raw materials. Resistance training gives it the stimulus. But there is a third layer: the cellular signal that tells your body to actually synthesize new muscle tissue from those materials.
This is where PeptiStrong enters the picture.
PeptiStrong is a clinically studied fava bean peptide complex that activates the mTOR and Phospho-S6 pathways, the cellular switches that drive muscle protein synthesis. It also suppresses myostatin (the protein that limits muscle growth) and reduces the activity of Atrogin-1 and MuRF1, two key drivers of muscle breakdown.
Why this matters for GLP-1 users specifically: When you are in a caloric deficit, your body's natural muscle protein synthesis rate decreases. PeptiStrong has been clinically shown to increase muscle protein synthesis rates during recovery periods, which is exactly the biological scenario a GLP-1 user faces: reduced calorie intake combined with the need to preserve existing muscle tissue.
The clinical data:
- 144% faster strength recovery in a randomized, double-blind trial (Nutrients, 2023)
- 56% reduction in myostatin, the protein that inhibits muscle growth (p = 0.006)
- Increased muscle protein synthesis rates during remobilization (The Journal of Nutrition, 2023)
- 17% increase in strength and double the reps to exhaustion (BMJ Nutrition, 2025)
- Muscle biopsy data confirming increased muscle fiber count (genuine regeneration)
Dosing: The clinically studied dose is 2,400mg per day. STร LK SURGE 185 delivers this exact amount in two capsules. Non-hormonal, stimulant-free, and fully stackable with any other supplement or medication protocol. As always, consult your prescribing physician before adding any supplement to your GLP-1 regimen.
Creatine is the most researched sports supplement in history, with over 500 published studies supporting its safety and effectiveness. It works by increasing your muscles' stores of phosphocreatine, which fuels short bursts of high-intensity effort.
For GLP-1 users, creatine offers two specific benefits:
- Preserves training performance: Even when you are eating fewer calories, creatine helps you maintain strength in the gym, which is essential for the muscle-preserving stimulus of resistance training
- Supports lean mass retention: Research has shown that creatine supplementation during caloric restriction can help preserve lean body mass
Dosing: 3 to 5 grams of creatine monohydrate per day. No loading phase needed. Mix with water or add to a shake. Creatine and PeptiStrong work through completely different mechanisms and stack cleanly together.
The scale tells you one number: total body weight. It does not tell you how much of that weight is fat versus muscle. If you are on a GLP-1 medication and serious about preserving muscle, you need a way to track what is actually happening beneath the surface.
Options for tracking body composition:
- DEXA scan: The gold standard. Measures fat, muscle, and bone density with high accuracy. Available at many clinics. Aim for one every 3 to 6 months.
- Bioelectrical impedance (BIA) scales: Less accurate than DEXA but useful for tracking trends over time. Use under consistent conditions (same time of day, hydration level).
- Tape measurements: Waist circumference plus arm/thigh measurements can give a rough picture of where changes are happening.
- Strength tracking: If your lifts are holding steady or increasing while your weight drops, you are likely preserving muscle. If your strength is dropping significantly, your body is probably losing lean mass.
The Missing Piece in Your GLP-1 Protocol
Protein gives the bricks. Training gives the stimulus. SURGE 185 gives the cellular signal to build. 2,400mg PeptiStrong, exactly as clinically studied.
The Complete Daily Protocol for GLP-1 Users
Here is how all five strategies fit together into a practical daily routine:
Morning (rest days): Take 2 capsules of SURGE 185 (2,400mg PeptiStrong) with water. Eat a high-protein breakfast (30+ grams). Take 3 to 5g creatine monohydrate.
Post-workout (training days): Take 2 capsules of SURGE 185. Consume a protein shake or high-protein meal within 1 to 2 hours (40+ grams protein). Take 3 to 5g creatine with your shake.
Throughout the day: Hit your protein target (1.2 to 1.6g per kg body weight). Prioritize protein-dense foods at every meal. Stay hydrated.
Weekly: Resistance train 2 to 3 times. Track your lifts. Monitor body composition monthly.
Who Should Be Most Concerned About GLP-1 Muscle Loss?
- People over 40: Age-related muscle loss (sarcopenia) is already occurring naturally. Adding GLP-1 induced muscle loss on top of that compounds the problem. This group has the most to lose and the most to gain from a proactive muscle preservation strategy.
- Anyone losing weight rapidly: The faster the weight loss, the higher the proportion that tends to come from lean mass. If you are losing more than 2 to 3 pounds per week consistently, muscle preservation should be a top priority.
- People not resistance training: Without the stimulus of resistance exercise, your body has no strong reason to preserve muscle tissue during a caloric deficit. This group is at the highest risk of disproportionate lean mass loss.
- Anyone eating less than 1g of protein per kg of body weight: Insufficient protein intake during weight loss is a primary driver of muscle breakdown. If your appetite suppression is making it hard to eat enough protein, supplementation becomes especially important.
Lose the Fat. Keep the Muscle.
SURGE 185 delivers the full 2,400mg clinical dose of PeptiStrong in two capsules. Clinically shown to support muscle protein synthesis, suppress myostatin, and accelerate recovery. Non-hormonal. Stimulant-free. Built to stack.
โญ 4.9/5 from 3,500+ verified reviews ย ย |ย ย 30-day money-back guarantee ย ย |ย ย 3rd party tested every batch
โบ Shop SURGE 185Frequently Asked Questions
Sources
- Kerr, A., et al. "Improved Strength Recovery and Reduced Fatigue with Suppressed Plasma Myostatin Following Supplementation of a Vicia faba Hydrolysate, in a Healthy Male Population." Nutrients 15.4 (2023): 986.
- Weijzen, M.E.G., et al. "Vicia faba Peptide Network Supplementation Does Not Differ From Milk Protein in Modulating Changes in Muscle Size During Short-Term Immobilization and Subsequent Remobilization, but Increases Muscle Protein Synthesis Rates During Remobilization in Healthy Young Men." The Journal of Nutrition 153.6 (2023): 1718-1729.
- BMJ Nutrition, Prevention and Health 2025;bmjnph-2024-001050.
- Neeland, I.J., et al. "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Diabetes, Obesity and Metabolism (2024).
- Nauck, M.A. "GLP-1 receptor agonists and next-generation incretin-based medications." The Lancet (2026).
- Nuritas. "PeptiStrong: A Revolutionary Solution to Combat Muscle Loss Caused by Weight Reduction Programs." (2024).